# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-26-059416
Filing Date
2026-05-12
Accepted
2026-05-12 16:18:59
Documents
104
Period of Report
2026-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | ibio-20260331x10q.htm iXBRL | 10-Q | 2027470
2 | EX-31.1 | ibio-20260331xex31d1.htm | EX-31.1 | 15609
3 | EX-31.2 | ibio-20260331xex31d2.htm | EX-31.2 | 18769
4 | EX-32.1 | ibio-20260331xex32d1.htm | EX-32.1 | 10994
5 | EX-32.2 | ibio-20260331xex32d2.htm | EX-32.2 | 5687
6 | GRAPHIC | ibio-20260331x10q001.jpg | GRAPHIC | 68684
7 | GRAPHIC | ibio-20260331x10q002.jpg | GRAPHIC | 67793
| Complete submission text file | 0001104659-26-059416.txt |  | 10385482

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | EX-101.SCH | ibio-20260331.xsd | EX-101.SCH | 83543
9 | EX-101.CAL | ibio-20260331_cal.xml | EX-101.CAL | 50991
10 | EX-101.DEF | ibio-20260331_def.xml | EX-101.DEF | 388894
11 | EX-101.LAB | ibio-20260331_lab.xml | EX-101.LAB | 591406
12 | EX-101.PRE | ibio-20260331_pre.xml | EX-101.PRE | 571012
108 | EXTRACTED XBRL INSTANCE DOCUMENT | ibio-20260331x10q_htm.xml | XML | 1650336

Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

EIN.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35023 | Film No.: 26968882
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)